APA (7th ed.) Citation

V, C., P, M., C, L., H, P., M, T., JC, G., . . . B, F. (2023). Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France. International journal of cancer, 152(8), 1659. https://doi.org/10.1002/ijc.34326

Chicago Style (17th ed.) Citation

V, Corvest, et al. "Late Toxicity Comparison of Alkylating-based Maintenance Regimen with Cyclophosphamide (VAC) Vs Ifosfamide (VAI) in Ewing Sarcoma Survivors Treated in the Randomized Clinical Trial Euro-EWING99-R1 in France." International Journal of Cancer 152, no. 8 (2023): 1659. https://doi.org/10.1002/ijc.34326.

MLA (9th ed.) Citation

V, Corvest, et al. "Late Toxicity Comparison of Alkylating-based Maintenance Regimen with Cyclophosphamide (VAC) Vs Ifosfamide (VAI) in Ewing Sarcoma Survivors Treated in the Randomized Clinical Trial Euro-EWING99-R1 in France." International Journal of Cancer, vol. 152, no. 8, 2023, p. 1659, https://doi.org/10.1002/ijc.34326.